| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Fidelity Management & Research Company LLC
|
8.455m | 10.27% | -884.817k | Jun 30 2026 |
| 2 |
RA Capital Management, LP
|
7.220m | 8.77% | +7.220m | Jul 31 2026 |
| 3 |
Highbridge Capital Management, LLC
|
6.190m | 7.52% | +6.190m | Mar 31 2026 |
| 4 |
Janus Henderson Investors
|
5.171m | 6.28% | +1.863m | Jun 30 2026 |
| 5 |
Vanguard Capital Management, LLC
|
3.651m | 4.43% | +749.354k | Jun 30 2026 |
|
1
Fidelity Management & Research Company LLC
|
10.27%
8.455m
|
|
2
RA Capital Management, LP
|
8.77%
7.220m
|
|
3
Highbridge Capital Management, LLC
|
7.52%
6.190m
|
|
4
Janus Henderson Investors
|
6.28%
5.171m
|
|
5
Vanguard Capital Management, LLC
|
4.43%
3.651m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 37.27% of Inovio Pharmaceuticals, Inc., with Fidelity Management & Research Company LLC the biggest at 10.27%, followed by RA Capital Management, LP (8.77%) and Highbridge Capital Management, LLC (7.52%). |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Inovio Pharmaceuticals, Inc. has risen over the past 12 months from around 14.2% to 21.4% of the float. More and more market participants are betting on falling prices. That reflects growing skepticism, but also carries upside potential through a possible short squeeze. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


